**Health**
## WHO Issues New Global Guidelines: Urges Against Obesity Drugs for Children Under 10, Prioritizes Lifestyle Interventions
**GENEVA – The World Health Organization (WHO) has released updated global guidelines strongly advising against the use of weight-loss medications, including injectable obesity drugs, for children under the age of 10. Instead, the leading global health authority emphasizes a primary focus on comprehensive lifestyle interventions centered around healthy eating habits and regular physical activity.**
In a significant shift towards preventative and non-pharmacological approaches for young children, the WHO’s new directive underscores the potential risks and the lack of long-term data for weight-loss medications in very young populations. The guidelines advocate for a foundational strategy that addresses the root causes of childhood obesity through sustainable and family-centred methods.
“Our new guidelines are clear: for children under 10, the priority must be on establishing healthy eating patterns and integrating physical activity into daily life,” stated a WHO spokesperson. “These fundamental interventions are not only safer but also lay the groundwork for lifelong healthy habits, empowering families to make sustainable changes rather than relying on pharmaceutical solutions.”
The recommendation comes amidst a global rise in childhood obesity, a complex public health challenge with significant implications for future adult health. While acknowledging the role of medication in specific, older adolescent populations under strict medical supervision, the WHO maintains that the developing bodies and systems of children under 10 are not suitable candidates for drug interventions designed to manage weight.
Weight-loss injections, often referencing GLP-1 receptor agonists, have gained popularity for adult weight management. However, their use in very young children raises concerns regarding potential side effects, unknown long-term impacts on growth and development, and the potential to medicalize what should be a holistic, family-based approach to health.
The WHO’s guidance calls upon healthcare providers, policymakers, and parents to:
* **Promote Healthy Environments:** Create school, home, and community settings that support nutritious food choices and opportunities for physical play.
* **Educate and Empower Families:** Provide resources and education on balanced diets, portion control, and the importance of active lifestyles.
* **Focus on Behavioral Changes:** Implement strategies that encourage positive eating behaviors and reduce sedentary time, involving the entire family.
* **Avoid Early Medicalization:** Reserve pharmacological interventions for carefully selected older adolescents, and only after exhaustive lifestyle modifications have been attempted and failed, under strict medical guidance.
These new global guidelines serve as a critical reminder that while the challenge of childhood obesity is urgent, the solution for the youngest demographic lies in fostering a healthy environment and instilling habits that support well-being from an early age, rather than turning prematurely to pharmaceutical interventions.
